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Abstract
The Th17 cytokine, IL-22, regulates host immune responses to extracellular pathogens. Whether IL-22 plays a role in viral
infection, however, is poorly understood. We report here that Il222/2 mice were more resistant to lethal West Nile virus
(WNV) encephalitis, but had similar viral loads in the periphery compared to wild type (WT) mice. Viral loads, leukocyte
infiltrates, proinflammatory cytokines and apoptotic cells in the central nervous system (CNS) of Il222/2 mice were also
strikingly reduced. Further examination showed that Cxcr2, a chemokine receptor that plays a non-redundant role in
mediating neutrophil migration, was significantly reduced in Il222/2 compared to WT leukocytes. Expression of Cxcr2
ligands, cxcl1 and cxcl5, was lower in Il222/2 brains than wild type mice. Correspondingly, neutrophil migration from the
blood into the brain was attenuated following lethal WNV infection of Il222/2 mice. Our results suggest that IL-22 signaling
exacerbates lethal WNV encephalitis likely by promoting WNV neuroinvasion.
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Introduction
IL-22 is a member of the IL-10-related cytokine family [1], and
has been implicated in both chronic inflammatory diseases and
infectious diseases. The tissue-modulating function of IL-22 in
response to the immune system sets it apart from IL-10, which
regulates immune cell functions [2,3]. Although known as a Th17
cytokine, IL-22 is also expressed by a wide range of immune cells,
including NK T, cd T, and NK cells [4–6]. However, its receptor
is exclusively produced by tissue cells, including epithelial and
endothelial cells [7,8]. Activation of IL-22 receptor leads to Stat3,
Stat1, MAPK kinase and Akt signaling, which then results in
diverse outcomes such as cell proliferation and survival [9–13].
The role of IL-22 in inflammatory and infectious diseases varies
with tissue and disease conditions. IL-22 contributes to pathogen-
esis of psoriasis by inducing the proinflammatory S100 family of
calcium binding proteins [5,7] and plays a role in multiple sclerosis
by promoting leukocyte infiltration into the brain [14]. However,
IL-22 protects the liver from immune system-mediated damage
during hepatitis [12,13]. Upon microbe assaults, especially
extracellular pathogens such as K. pneumonia the host increases
IL-22 expression, which helps maintain epithelial barriers and
induces secretion of anti-microbial peptides by the epithelia [15].
Although IL-22 is also induced by virus [16,17] and has been
implicated in anti-HIV function [18], its in vivo role in viral
infections has yet to be defined.
Mosquito-borne viruses in the Flaviviridae family have recently
emerged as a threat to human health. One of the life-threatening
flaviviruses, West Nile virus (WNV), is maintained worldwide in an
enzootic cycle between avian hosts and mosquito vectors. Since
the outbreak in New York City in 1999, WNV has been rapidly
spreading throughout North America and has caused thousands of
deaths in the U.S.A. Infection is usually asymptomatic in most
cases, but elicits fever, meningitis, encephalitis or acute flaccid
paralysis in 20–40% of individuals [19].
The mechanisms by which neurotropic flaviviruses including
WNV enter the central nervous system (CNS) are not well
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understood. In theory, WNV can enter the brain through many
routes including 1) endothelial tight junctions [20–26], 2) direct
infection of endothelial cells [23], 3) infected leukocytes that traffic
to the CNS [26], 4) infection of olfactory neurons [26] and 5)
direct axonal retrograde transport from infected peripheral
neurons [27]. Although infiltrating CD8 T cells are crucial for
controlling WNV dissemination in the CNS [28–31], they are
recruited to the CNS too late after viral invasion [day 6 post-
infection (p.i.) in mouse models] to prevent initial infection [32].
Early entry of neutrophils (day 4 p.i. in the mouse) that carry a
heavy load of neurotropic virus may be deleterious to host [33]
and contribute to CNS inflammation [34].
Here, we studied the in vivo role of IL-22 in WNV infection and
found that IL-22 contributed to the early entry of neutrophils into
the CNS. Results show that IL-22 signaling contributes to WNV
pathogenesis in the CNS.
Materials and Methods
Animals and Infection
All animals were housed in our state-of-the-art animal facility at
Yale University. Age and sex-matched animals (5–8 weeks old
C57BL/6 and II222/2) were infected with WNV at a sublethal
dose of 20 plaque forming units (PFU) via an intracranial (i.c)
route, or 200 PFU via footpad subcutaneous (s.c) route, and mice
were maintained in a BSL3 animal facility. Il222/2 mice have
been described previously [13]. WNV (strain CT2741) was
isolated from naturally-infected wild birds and in vitro passaged
once in Vero cells. Animals were thoroughly perfused with 50 ml
of 1x ice-cold phosphate buffered saline (PBS) prior to tissue
analyses. All animal protocols were approved by the Yale
University Institutional Animal Care & Use Committee (protocol
10404).
Chemicals and Antibodies
Anti-IL-22Ra1, Cxcr2-Phycoerythrin, mouse Cxcl1 and IL-22
ELISA kits were purchased from R&D Systems (# MAB4294,
FAB2164P, DY453, M2200), Anti-CD45 was from Serotec (1:200;
clone IBL-3/16; used as a pan-leukocyte marker), and anti-mouse
neutrophils was from Cedarlane Labs (1:200; clone 7/4). Mouse
anti-WNV was a kind gift from Dr. John F. Anderson at the
Connecticut Agricultural Experimental Station, New Haven, CT.
Recombinant human IL-22 was purchased from PROSPEC (Ness
Ziona, Israel), allophycocyanin (APC)-labeled anti-Ly6G (Gr-1)
and fluorescein (FITC)-labeled anti-CD45 from BD Pharmingen
(# 553129 and 553080).
Cell Culture
Human PMNs were isolated from freshly-drawn blood accord-
ing to a previous study [33]. PMNs were infected with WNV at a
multiplicity of infection of 1 (MOI=1) for 24 hours. Primary
human brain microvascular endothelial cells (HBVECs) (Scien-
Cell, #1000) were cultured in formulated ECM medium
(ScienCell, #1001) and treated with human recombinant IL-22
at a concentration of 200 ng/ml. Total RNAs were isolated after
infection/treatment, and then reverse-transcribed into cDNA
using the BioRad iScript cDNA synthesis kit.
Polymorphonuclear Leukocyte (PMN) Transendothelial
Migration Assay
36104 HBVECs were grown in cell culture inserts (pore size 3.0
micron) coated with human fibronectin (BD Biosciences #
354543) for 3 days, allowing formation of a monolayer [14]. We
assured integrity of the HBVEC layer by assessing Evans blue
leakage. IL-22 was added to the wells of a culture plate (lower
chamber) and 24 hours later the inserts was washed with PBS
twice gently. 26105 PMNs in 0.5 ml medium were added to the
inserts and the live cells in the lower chamber (1.0 ml medium)
were counted after 18 h. We counted 4 times and took the average
for each well. Primary mouse brain vascular endothelial cell
(MBVEC) monolayer [35] were pre-treated with 1 mg of purified
rat IgG or rat anti-mouse IL-22R (R&D # MAB4294) for
24 hours followed by 24 h-treatment with 200 ng/ml of mouse
IL-22. 2.56105 purified mouse blood PMNs were added to the
upper chamber and the numbers of PMNs that migrated out of the
upper chamber across the MBVEC monolayer down to the lower
chamber were counted after 18 hours.
Fluorescence-activated Cell Scanning (FACS) Analyses of
Whole Blood Cells and Brain Leukocytes
Mice were infected with 200PFU of WNV via s.c. footpad. At
day 4 p.i., 200 ml of whole blood was collected for immunostain-
ing. Briefly, 5 mg of mouse IgGs was added to the blood samples,
which was then incubated at room temperature for10 min.
0.25 mg of FITC-labeled anti-CD45, APC-labeled anti-Ly6G
(Gr-1) and PE-labeled anti-Cxcr2 was added to the blood, which
was then incubated at 4ufor 40 min. Cells were then pelleted,
washed, fixed and analyzed by FACS using LSR II Flow
cytometer (BD Bioscience). The mean fluorescence intensity of
Cxcr2 on CD45+Ly6G+Cxcr2+ cells was quantified using Flowjo
software. Brain leukocytes were isolated as described previously
[32].
Microscopy and Tunel Staining
Mouse tissues were fixed in 4% paraformaldehyde (PFA) and
sectioned in paraffin. Immunofluorescence staining was performed
following published standard protocols [36]. Terminal deoxynu-
cleotidyl transferase dUTP nick end labeling (TUNEL) staining
was carried out using a kit from Promega Corporation. Using this
procedure, apoptotic nuclei are stained dark brown, and sections
were counter-stained with hematoxylin (blue color). TUNEL
images were acquired using a Zeiss AxioImager Z1 microscope.
Sections reacted with anti-WNV antibody in presence of CD45 or
7/4 antibodies were incubated with appropriate secondary
antibodies conjugated with Alexa Fluor 488 and Alexa Fluor
594 antibodies. The resulting sections were mounted in ProLongH
Gold fluorescence mounting media containing DAPI (as a nuclear
counter-stain) and imaged in independent channels using a
confocal microscope (Nikon C1 Eclipse) according to our
previously published methods [26].
Quantitative RT-PCR (qPCR)
Taqman qPCR was performed using gene-specific primers and
6FAM-TAMRA probes [36] or inventoried gene expression
primer-probe sets from Applied Biosystems (6FAM-MGB probes).
The primer sets for SYBRGreen PCR of human genes were:
CXCR2, forward 5-CCGGGCGTGGTGGTGAG and reverse 5-
AGACAGAGTCTCACTGTCG; CXCR4, forward 5-TCGTC-
CACGCCACCAACAGT and reverse 5-CTGTCATCTGCCT-
CACTG; CXCL1, forward 5-GCTTGCCTCAATCCTGCA and
reverse 5-CAATCCAGGTGGCCTCTGC; CXCL2, forward: 5-
GCTGCTGCTCCTGCTCCTG and reverse 5-CTTCGG-
TTTGGGCGCAGTG; CXCL5, forward 5-AAGGTGGCCA-
CGCTGGGGCAA and reverse 5-TGCAACGTCAGGCAG-
TTGCCCT.
IL-22 and West Nile Virus
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Figure 1. Il222/2 mice are resistant to lethal WNV infection. a) Plasma IL-22 levels of WT mice were measured by ELISA, and viremia was
quantified by q-PCR using WNV envelope gene (WNV-E) primers and probes and normalized with mouse actin. b) IL-22Ra1 transcripts in the WT
mouse brain were examined by q-PCR and normalized with actin, and viral loads were quantified by q-PCR for WNV-E and normalized with mouse
actin; *p,0.05; **p,0.01. Each dot represents one mouse. c) Immunofluorescence microscopy of IL-22Ra1 (red signal) in the WT mouse brain
(cerebral cortex is shown). DAPI nuclear counter-stain is shown in blue. Arrows indicate blood vessels, shown in higher-magnification insets. d)
Survival curve of Il222/2 vs. WT mice challenged with WNV. Mice were infected with 200 PFU of WNV via s.c. footpad injection and monitored daily for
survival for 21 days (n = 30 for WT and n=24 for Il222/2 mice). Data are pooled from 3 independent experiments.
doi:10.1371/journal.pone.0044153.g001
IL-22 and West Nile Virus
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Graphs and Statistics
Survival curves, charts and statistical analysis were performed
using PRISM 4 software (Graphpad Software, San Diego, CA).
Significance was assessed using unpaired two-tailed Students’ t-test
or nonparametric Mann-Whitney U test. For all analyses, a cutoff
p value of 0.05 was used.
Results
IL-22 Deficiency Confers Resistance to Lethal WNV
Infection
IL-22 is expressed by immune cells at a low constitutive level;
however, it is dramatically up-regulated under certain disease
conditions [3]. We first tested if WNV infection induced IL-22
expression. As shown in Figure 1A, circulating IL-22 protein
abundance was consistently increased from days 4 through 6 p.i by
6–20 fold compared to day 0. Interestingly, IL-22 levels remained
high even though viremia receded at day 6 p.i. (Fig. 1A). The IL-
22 receptor consists of 2 subunits, IL-10Rb and IL-22R. Unlike
IL-10Ra that is expressed by immune cells, IL-22R is exclusively
produced by tissue cells [7,8]. Indeed, we failed to detect IL-22R
expression in blood leukocytes by RT-PCR. The mRNA levels of
IL-22R in the brain, however, were readily detectable and
increased by 5–10 fold at day 4 p.i. compared to day 0.
Interestingly, IL-22R expression in the brain decreased at later
time-points p.i. despite increasing viral loads (Fig. 1B, 1C). We
then examined the survival response of IL-22 knockout mice
(Il222/2) to WNV challenge. Surprisingly, in contrast to its
protective role in bacterial infection, IL-22 was detrimental to
mice when challenged with WNV. Specifically, Il222/2 mice
survived lethal WNV infection better than their wild-type (WT)
counterparts (median survival 17.5 versus 9 days, p,0.01), and
began to die on average, 2 days later (Fig. 1D).
Central but not Peripheral Control of West Nile Virus in
Il222/2 Mice
IL-22 signaling has been shown to control bacterial infection by
helping to mount antimicrobial immune responses [6,15]. We
asked if IL-22 was important for controlling WNV dissemination
and mobilizing peripheral anti-viral immune responses. There
were no differences in viral loads in the blood or spleen between
Il222/2 and wild type mice from day 1 through day 6 p.i. (Fig. 2A,
2B). Furthermore, ifnb and tnfa transcripts in spleens of Il222/2
mice remained largely similar to those of WT mice (Fig. 2C).
Consistently, no significant differences in tnfa transcripts were
observed in whole blood (Fig. 2D). These data indicate that IL-22
does not influence WNV infectivity and plays a sub-dominant role
in these cytokine responses in the periphery.
We then next examined WNV burden and cytokine expression
in the CNS. Consistent with the survival result (Fig. 1D), CNS
viral loads were significantly reduced in Il222/2 mice compared
with WT at days 6 and 8 p.i. (Fig. 3A). The expression kinetics of
select cytokines in the CNS of WT mice following WNV infection
was first determined, with the highest induction noted at day 8 p.i
compared to day 0 (Fig. S1). The expression levels of inflammatory
cytokines, tnfa and il6, were decreased at day 8 p.i. in Il222/2
when compared to WT (Fig. 3B). We next examined histopathol-
ogy in brain tissues of WT and Il222/2 mice. Consistent with the
viral load results, TUNEL positive cells in Il222/2 brains were
fewer in number than WT mice (Day 6, 182621 v.s 2864, per
field under 106 microscope; day 8, 241627 v.s. 102613.
p,0.05). A similar pattern of results was detected in multiple
brain regions, including the cerebral cortex (Fig. 3C), olfactory
bulb, striatum, cerebellum, and brainstem. As shown in Figure 3D,
the TUNEL scores of Il222/2 mice were significantly lower than
WT mice on days 6 and 8 p.i.(Fig. 3D). Leukocyte infiltration into
the CNS is a hallmark of WNV encephalitis, and we observe this
phenotype in mouse models of lethal WNV encephalitis [29].
Indeed, CD45+ leukocytes/microglia were readily detected in
various brain regions of WT mice, particularly in areas earmarked
by WNV antigen expression. However, the number of CD45+ cells
was greatly reduced in Il222/2 mouse brain regions at both days 6
and 8 p.i.(Fig. 3E, Fig. S2).
IL-22 Facilitates WNV Entry into the CNS
Since Il222/2 mice had lower viral loads than WT mice in the
CNS (Fig. 3A) but not in the periphery (Fig. 2A), we hypothesized
that IL-22 facilitates virus entry into the CNS. To exclude the
possibility that IL-22 deficiency favored viral clearance in the
brain, we performed intracranial inoculation with a low dose of
WNV. Surprisingly, viral loads in the brain of Il222/2 mice were
much higher than those in WT animals. Consistently, expression
of the proinflammatory cytokine TNF was also significantly
increased (Fig. 4A). These results, nevertheless, disproved the
possibility that IL-22 deficiency favored viral clearance in the CNS
when virus was inoculated via s.c route, and suggested that IL-22
signaling facilities WNV entry to the CNS.
Neutrophils are the predominant cell infiltrate in cerebrospinal
fluid from patients with WNV meningitis and encephalitis [37,38].
These cells have been suggested to be a key reservoir for WNV in
the blood, and deletion of Cxcr2, a chemokine receptor that
mediates neutrophil migration, alleviated WNV infection of the
CNS in a mouse model [33]. We next asked whether IL-22
impacted Cxcr2 expression and regulated CNS infiltration of
neutrophils. As shown in Figure 4B, cxcr2 mRNA expression by
blood leukocytes was significantly lower in Il222/2 than that in
WT mice at day 4 p.i., a time when neutrophils begin penetrating
the CNS in our peripheral murine WNV infection model. This
effect was specific to cxcr2; since expression of the chemokine
receptors ccr5 and cxcr4 remained similar betweenWT and Il222/2
mouse peripheral blood cells (Fig. 4B). To determine whether the
population of Cxcr2-positive blood cells or average Cxcr2
expression level was affected in Il222/2, we then analyzed the
numbers and mean fluorescence intensity of CD45 (pan leukocytes)
Ly6G (granulocytes and monocytes) Cxcr2-positive cells in the
blood. At day 4 p.i., the numbers of this population were similar
betweenWT and Il222/2, but theMFI of Cxcr2 was much lower in
Il222/2 (Fig. 4C, Fig. S3), suggesting that IL-22 contributes to
Cxcr2 expression. Cxcl1 and Cxcl5, Cxcr2 ligands that are
expressed also by brain cells, stimulate chemotaxis of neutrophils
by interacting with Cxcr2. We further examined the abundance of
cxcl1 and cxcl5 transcripts in brains of WT and Il222/2. At day 4
and 6 p.i., cxcl1 and cxcl5 transcripts were decreased by two-fold
respectively in Il222/2 brains compared to WT (Fig. 4D),
Figure 2. Phenotypic characterization of Il222/2 mice after WNV challenge. Mice were infected with 200 PFU of WNV via s.c. footpad
injection. Viral loads (shown by WNV-E expression and plaques per mg proteins) and cytokine/chemokine transcripts were quantified by q-PCR and
normalized with mouse actin. Viral loads are shown from a) whole blood cells, b) spleen at the indicated days p.i. Cytokine transcripts are shown from
c) spleen at day 4 p.i., d) in blood cells at the indicated days p.i. *p,0.05; **p,0.01. Each dot represents one mouse, and the horizontal lines are the
medians of the results.
doi:10.1371/journal.pone.0044153.g002
IL-22 and West Nile Virus
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Figure 3. Phenotypic characterization of Il222/2 mice after WNV challenge. Mice were infected with 200 PFU of WNV via s.c. footpad
injection. On days4, 6 and 8 p.i., a) viral loads (shown by WNV-E expression and plaques per mg proteins) and b) cytokine transcripts from the brain
were quantified by q-PCR and normalized with mouse actin. c) Paraffin embedded brain sections were reacted with TUNEL. Graphs indicate cerebral
IL-22 and West Nile Virus
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suggesting that IL-22 contributes to Cxcl1 and Cxcl5 expression.
The brain microvascular endothelial cells (BVECs) regulate
leukocyte traffic in part by producing a chemokine gradient. We
reasoned that IL-22 impacts chemoattractant expression by BVECs
and neutrophil migration across endothelia. Indeed, human
primary BVECs (HBVECs) upregulated CXCL1 and CXCL5
mRNA expression by over 3- and 40-fold respectively when treated
with recombinant IL-22 for 20 h (Fig. 4E). Similar results were
observed with mouse BVECs (Fig. S4A, S4B). These data indicate
that IL-22 aids in neutrophil recruitment by regulating chemoat-
tractant production at the blood brain barrier (BBB). To further
strengthen this point, we tested the ability of PMNs to cross a
HBVEC monolayer in the presence of IL-22. Indeed, after
HBVECs were treated with 50–200 ng/ml of IL-22 for 24 h, more
PMNs were found in the lower chamber than the control (0 ng/ml)
(Fig. 4F). We next employed mouse MBVECs to examine the
impact of IL-22 signaling on mouse PMNmigration. Similar results
were observed (Fig. 4G). Furthermore blocking IL-22 signaling
using a monoclonal anti-IL-22R reduced PMN transmigration
(Fig. 4G, 4H). In addition, in response to Cxcl1 the neutrophils from
WNV-infected Il222/2 mice transmigrated a MBVEC layer less
efficiently than those from WT (Fig. S4C). In vivo, at day 6 p.i., both
WNV and neutrophils were present in the WT, but nearly absent in
Il222/2 brains (Fig. 4I). This was further confirmed by FACS
analyses of brain neutrophils (CD45Ly6G positive) (Fig. 4J).
Interestingly, neutrophils in WT mouse brains co-localized with
WNV in the fairly vascularized meninges (Fig. 4I), further
suggesting that neutrophils may act as CNS virus carriers.
Discussion
The roles of IL-22 in inflammation and bacterial infections are
diverse [39]. However, its in vivo function in viral infections has yet
been defined. Our results support a novel concept that IL-22
regulates anti-viral responses, likely by refereeing neutrophil
infiltration of the CNS. Unlike Il10 deficiency or Tlr7 sufficiency,
which leads to enhanced innate immune responses and better
control of WNV infection in vivo [40,41], deletion of IL-22 had no
significant impact on innate immune responses to WNV. Rather,
Il222/2 mice demonstrated more resilience to s.c. lethal WNV
infection and reduced virus entry into the CNS.
Previous studies have shown that both IL-17 and IL-22
contribute to multiple sclerosis lesions by promoting transmi-
gration of Th17 lymphocytes across the blood brain barrier
[14]. Our results extend this idea into neutrophil biology, and
suggest that IL-22 facilitates neutrophil infiltration of the CNS
after WNV infection. Our statement is supported by several
lines of evidence. First, IL-22 signaling sustains expression of
Cxcr2, a neutrophil receptor that plays a critical role in
chemotaxis of these cells, after WNV challenge. WT animals
upon WNV challenge increased the serum levels of IL-22 and
Cxcr2 expression consistently over the time of observation (day
2 through 4). Il222/2 mice increased Cxcr2 expression at day 3
(compared to day 2), but failed to maintain high levels of Cxcr2
at day 4 p.i. These data suggest that IL-22 serves to sustain
Cxcr2 expression after peripheral infection has been established.
However, it is unlikely that IL-22 directly acts on neutrophils to
upregulate Cxcr2 expression as neutrophils do not express IL-
22R. Rather, modulation of Cxcr2 by IL-22 may be indirect via
IL-22-induced proinflammatory mediators such as TNF and IL-
8 [42], potent inducers of Cxcr2. Second, IL-22 signaling can
induce the expression of CXCR2 ligands, CXCL1 and CXCL5,
in endothelial cells. In the absence of IL-22, cxcl1 and cxcl5
mRNA in mouse brains was reduced after WNV infection. The
decrease in cxcl1 appeared at day 4, while the difference in cxcl5
was observed at day 6. This might due to the differential
kinetics of gene expression during WNV infection. In agreement
with a previous study [43], in vivo cxcl1 was an early responsive
gene and upregulated by WNV infection dramatically; while
cxcl5 was only modestly induced at a later time. Third,
activation of IL-22 signaling in BVECs promotes neutrophil
migration across BVEC monolayer. In vitro, treatment of BVECs
with recombinant IL-22 allowed neutrophils to cross BVEC
layer more efficiently. In vivo, IL-22 deficiency reduced the
number of neutrophils in brain perivascular spaces and
parenchyma after WNV infection. This is in agreement with
a recent study showing that IL-22 induces transient elevation of
circulating neutrophils via CXCL1 in the liver [44]. Taken all
together, these data suggest that IL-22 favors neutrophil
recruitment to the CNS by regulating CXCR2-CXCL1 axis.
Leukocyte infiltrates in the CNS may be favorable of virus
clearance, but also neuron inflammation. Clearly, infiltrating
CD8 T cells are crucial for controlling WNV dissemination in
the CNS [28–31], but these cells also exacerbate CNS
pathology induced by Japanese encephalitis virus, the closest
relative of WNV in the Flaviviridae family [45]. Accumulation of
monocytes may be harmful to mice infected with WNV [46].
However, Ccr2-mediated Ly6Chimonocytosis and accumulation
in the brain is protective against WNV infection [47]. The most
abundant leukocytes, neutrophils, are the predominant cell
infiltrate in the cerebrospinal fluid from patients with WNV
meningitis and encephalitis [37,38], and in mice they are
present in the brain parenchyma as early as day 4 p.i. [32].
These cells have also been demonstrated to support WNV
infection very effectively [33]. It is thus plausible that WNV is
carried by neutrophils to cross the blood brain barrier. Indeed,
our data show that neutrophils in WT mouse brains co-localized
with WNV in the vascularized meninges and depletion of
neutrophils protected mice from lethal WNV infection [33].
Neutrophils in the CNS could also contribute to CNS
inflammation [34] and BBB disruption by producing inflamma-
tory mediators such as matrix metalloproteinases.
Similar to Cxcr2 knockout mice challenged with WNV [33],
Il222/2 mice died 2 days later than WT, suggesting a delayed
entry of virus into the CNS. The overall mortality of cxcr22/2 was
as the same as WT, while Il222/2 survived better than WT. A
possible explanation is that Il222/2 showed a decrease in Cxcr2
expression after the peripheral infection had established (day 4
p.i.), and Il222/2 were also defective in brain Cxcl1 and Cxcl5
expression. Thus IL-22 does not influence neutrophil function,
either favoring WNV dissemination initially or then controlling
WNV infection later. Rather IL-22 specifically regulates neutro-
phil migration and thus WNV entry into the CNS after peripheral
infection has been established. Surprisingly though, IL-22
appeared beneficial to the host when virus was directly inoculated
into the brain. This is in agreement with previous observations
cortices representative of 5 mice per group. d) TUNEL scores were assessed using a semi-quantitative scale (from 0–3, with 3 indicating the greatest
number of TUNEL positive cells); *p,0.05; **p,0.01, and the arrows indicate apoptotic cells. e) Cryosectioned brain samples from day 6 p.i. were
stained for WNV envelope protein (green), CD45 (as a pan-leukocyte marker; red), and DAPI (blue) and utilized for laser scanning confocal microscopy
(20X images are shown and are representative of n= 5 mice per group).
doi:10.1371/journal.pone.0044153.g003
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showing that IL-22 was implicated in the control of Theiler’s virus
dissemination in the spinal cord when virus was inoculated
intracerebrally [48]. It is likely that IL-22 produced by the CNS
resident cells may restrict viral dissemination by inducing local
immune response such as defensins [7], potent anti-viral peptides
[49]. However, activation of IL-22 signaling could also have
immunopathogenic effects, leading to exacerbated disease condi-
tions [5,24,48]. Nonetheless, our results demonstrate that IL-22
signaling facilitates WNV pathogenesis in mice, likely by
promoting infiltration of infected neutrophils from the blood into
the brain.
Supporting Information
Figure S1 Expression kinetics of cytokines following
WNV infection. Mice were infected with 200 PFU of WNV via
s.c. footpad injection. The mRNA levels of indicated cytokines
from whole blood cells or brain cells were quantified by Taqman
q-PCR and normalized with beta actin gene. Each dot represents
one mouse and the horizontal line indicates the median of the
results. Significant induction of cytokines in blood cells from days 1
through 5, and in the brain of day 8 are observed compared with
uninfected (day 0).
(PDF)
Figure S2 Reduced WNV histopathology in Il222/2
brains. Mice were infected with 200 PFU of WNV via s.c.
footpad injection. At day 8 p.i., mice were euthanized and
perfused. Cryosectioned brain samples from day 8 p.i. were
stained for WNV envelope protein (green), CD45 (as a pan-
leukocyte marker; red), and DAPI (blue) and utilized for laser
scanning confocal microscopy (20X images are shown and are
representative of n= 5 mice per group).
(PDF)
Figure S3 FACS analysis of blood cells. Mice were infected
with 200 PFU of WNV via s.c. footpad injection. Blood cells at day
4 p.i. were stained for CD45-FITC, Ly6G-APC, and a) isotype
control (rat IgG2A) or Cxcr2-PE b) from WT mice, or c) from
Il222/2 mice.
(PDF)
Figure S4 IL-22 signaling promotes PMNs migration. a)
Induction of cxcl by IL-22 in MBVEC. MBVECs were treated with
200 ng/ml of mouse IL-22 for the indicated time duration. The
mRNA levels of cxcl1 and cxcl5 were quantified by quantitative
RT-PCR and normalized with mouse beta actin gene. *p,0.05.
b) Detection of MBVEC IL-22R by immunoblotting (IB). c)
Migration of blood PMNs from WT or Il222/2 infected with
WNV for 4 days (blood was pooled from 8 mice) across a MBVEC
monolayer in the presence of 200 ng/ml mouse Cxcl1 after 24 h.
Each dot represents the mean cell number from one well.
*p,0.05.
(PDF)
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